Axon assisted a Dutch oncology company, developing small molecule inhibitors for the precision treatment of cancer, with the structuring and completion of its Series A financing round. We advised on the drafting of all corporate resolutions, conditions precedent and related filtering and closing matters.
Updates
Explore our latest insights, regulatory updates, and strategic reports for the life sciences sector.
Type
Sectors (2)
Expertises
Advertising and Claims
Commercial Contracts
Corporate, Governance and Boardroom Counselling
Data Protection, (Cyber)security and AI
Due Diligence
Environmental and Sustainability
Financing and M&A
Intellectual Property and Licensing
Litigation
Regulatory Compliance and Enforcement
Spin-out and Starter Advisory
Subsidies and Grants
23 results
Newest first
Healthcare
Corporate, Governance and Boardroom Counselling
Financing and M&A
Testimonial
Healthcare
Medical Devices
Financing and M&A
Testimonial
Axon assisted the shareholders of a Dutch medtech company, specialising in epilepsy detection devices, in the sale of the company to a Scandinavian healthcare technology group. We advised on the transaction structure, share purchase documentation and related matters.
Diagnostics
Healthcare
Corporate, Governance and Boardroom Counselling
Financing and M&A
Testimonial
Axon assisted a Dutch IVD company in securing a EUR 24M equity financing round, advising on the transaction structure, investment documentation and related matters.